Yu H - Search Results

1

High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.

Qian B, Katsaros D, Lu L, Preti M, Durando A, Arisio R, Mu L, Yu H. Qian B, et al. Among authors: yu h. Breast Cancer Res Treat. 2009 Sep;117(1):131-40. doi: 10.1007/s10549-008-0219-7. Epub 2008 Oct 19. Breast Cancer Res Treat. 2009. PMID: 18932017

2

Insulin-like growth factors and breast cancer risk in Chinese women.

Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR, Berkel HJ, Zheng W. Yu H, et al. Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):705-12. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12163322

3

Plasma sex steroid hormones and breast cancer risk in Chinese women.

Yu H, Shu XO, Shi R, Dai Q, Jin F, Gao YT, Li BD, Zheng W. Yu H, et al. Int J Cancer. 2003 May 20;105(1):92-7. doi: 10.1002/ijc.11034. Int J Cancer. 2003. PMID: 12672036

4

The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Risch HA, Puopolo M, Yu H. Lu L, et al. Among authors: yu h. Clin Cancer Res. 2006 Feb 15;12(4):1208-14. doi: 10.1158/1078-0432.CCR-05-1801. Clin Cancer Res. 2006. PMID: 16489075

5

Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential.

Wiley A, Katsaros D, Chen H, Rigault de la Longrais IA, Beeghly A, Puopolo M, Singal R, Zhang Y, Amoako A, Zelterman D, Yu H. Wiley A, et al. Among authors: yu h. Cancer. 2006 Jul 15;107(2):299-308. doi: 10.1002/cncr.21992. Cancer. 2006. PMID: 16773633 Free article.

6

Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Schwartz P, Yu H. Lu L, et al. Among authors: yu h. Gynecol Oncol. 2006 Dec;103(3):990-5. doi: 10.1016/j.ygyno.2006.06.006. Epub 2006 Jul 21. Gynecol Oncol. 2006. PMID: 16859738

7

Expression of MDR1 in epithelial ovarian cancer and its association with disease progression.

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Yu H. Lu L, et al. Among authors: yu h. Oncol Res. 2007;16(8):395-403. doi: 10.3727/000000006783980892. Oncol Res. 2007. PMID: 17913048

8

Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.

Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H. Lu L, et al. Among authors: yu h. Cancer Res. 2007 Nov 1;67(21):10117-22. doi: 10.1158/0008-5472.CAN-07-2544. Cancer Res. 2007. PMID: 17974952

9

ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy.

Smith S, Su D, Rigault de la Longrais IA, Schwartz P, Puopolo M, Rutherford TJ, Mor G, Yu H, Katsaros D. Smith S, et al. Among authors: yu h. J Clin Oncol. 2007 Nov 20;25(33):5172-9. doi: 10.1200/JCO.2007.11.8547. J Clin Oncol. 2007. PMID: 18024864

10

IGF-I in epithelial ovarian cancer and its role in disease progression.

Brokaw J, Katsaros D, Wiley A, Lu L, Su D, Sochirca O, de la Longrais IA, Mayne S, Risch H, Yu H. Brokaw J, et al. Among authors: yu h. Growth Factors. 2007 Oct;25(5):346-54. doi: 10.1080/08977190701838402. Growth Factors. 2007. PMID: 18236213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,499 results

Search Page

Filters